Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $1.12 Billion |
|---|---|
| Enterprise Value | $1.39 Billion |
| Earnings per Share | $-13.56 |
| Beta | 0.66 |
| Outstanding Shares | 93,312,054 |
| P/E Ratio | -6.13 |
|---|---|
| PEG | -16.7 |
| Price to Sales | 1.2 |
| Price to Book Ratio | 2.0 |
| Enterprise Value to Revenue | 1.35 |
| Enterprise Value to EBIT | -0.55 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.56 |
| Debt to Equity | 3.89 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.02%▼ 0.00% |
|---|---|
| Total Invested | $238,263▼ 9.58% |
| Investors Holding | 10▲ 3.00% |
Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical cond...